Asklepios Biopharmaceutical Inc. (Askbio), of Research Triangle Park, N.C., appointed Tim Kelly president of manufacturing.
Clearside Biomedical Inc., of Alpharetta, Ga., appointed George Lasezkay president and CEO.
Corcept Therapeutics Inc., of Menlo Park, Calif., appointed Gregg Alton to its board and chair of the corporate governance and nominating committee.
Flexion Therapeutics Inc., of Burlington, Mass., appointed Melissa Layman chief commercial officer.
G1 Therapeutics Inc., of Research Triangle Park, N.C., appointed Jack Bailey to its board and Soma Gupta chief commercial officer.
Myst Therapeutics Inc., of Los Angeles, appointed James Mulé, Michael Lotze, Pamela Ohashi, Chantale Bernatchez and Alex Aravanis to its scientific advisory board.
Plus Therapeutics Inc., of Austin, Texas, appointed Robert Lenk and Howard Clowes to its board, effective April 1, 2020.
Tscan Therapeutics Inc., of Waltham, Mass., appointed Douglas Fambrough to its board.
VBI Vaccines Inc., of Cambridge, Mass., appointed Damian Braga to its board.